期刊文献+

CXCR4和COX-2在膀胱癌中的表达及其意义 被引量:3

Expression and significance of CXCR4 and COX - 2 in bladder carcinama
暂未订购
导出
摘要 目的:探讨COX-2和CXCR4在膀胱癌中的表达及意义。方法:应用免疫组织化学方法检测30例膀胱癌患者CXCR4、COX-2蛋白表达,分析CXCR4和COX-2的表达与膀胱癌浸润程度的关系。结果:10例正常膀胱黏膜组织中,CXCR4、COX-2蛋白阳性表达率均为20%,30例膀胱癌组织中,其CXCR4、COX-2阳性表达率分别为77.5%、80%,P<0.01,差异有统计学意义。病变局限在黏膜层的癌组织,其CXCR4、COX-2蛋白阳性表达率分别为50%、61.1%;浸润深度达肌层组的癌组织CXCR4、COX-2蛋白阳性表达率分别为100%、95.5%,P<0.01,差异有统计学意义。经Spearman等级相关性分析表明,CXCR4和COX-2表达水平之间成正相关关系(rs=0.477,P<0.01)。结论:COX-2和CXCR4在浸润膀胱癌中均有较高表达,可以考虑作为膀胱癌早期的诊断、分析膀胱癌浸润程度的标志物。 Objective: To study the expression and relationship of CXCR4 and COX-2 in bladder carcinama.Methods: The expressions of CXCR4 and COX-2 were determined in 30 tissue specimens of bladder carcinoma by immunohistochemistry technique.Results: The positive expression rates of CXCR4 and COX-2 of control group and treatment group were 20%,20% and 77.5%,80%.CXCR4 and COX-2 expression of mucosa were 50%,61.1%,and that of muscular layer were 100%,95.5%.There was significant difference in two groups(P 0.01).There was positive correlation between CXCR4 and COX-2 in cancer group(r s = 0.477,P 0.01).Conclusion: The expression of CXCR4 and COX-2 may be used as new markers for early diagnosis and carcinomatous infiltration of patients with bladder carcinoma.
作者 陈忠军 佃俊
出处 《现代肿瘤医学》 CAS 2012年第4期771-773,共3页 Journal of Modern Oncology
关键词 膀胱癌 CXCR4 COX-2 bladder carcinoma CXCR4 COX-2
  • 相关文献

参考文献7

二级参考文献52

共引文献35

同被引文献34

  • 1任亮,侯树坤,王晓峰,叶海云,管考鹏.不同类型膀胱癌组织中环氧化酶-2的表达及意义[J].中华泌尿外科杂志,2006,27(12):830-832. 被引量:3
  • 2Takahashi A, Tsukamoto T, Tobisu K, et al. Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. Jpn J Clin Oncol, 2004, 34: 14-19.
  • 3Stein JP, Skinner DG. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol, 2006, 24: 296-304.
  • 4Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol, 1998, 160: 2015-2019.
  • 5Vazina A, Dugi D, Shariat SF, et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol, 2004, 171: 1830-1834.
  • 6Jensen JB, Ulhai BP, Jensen KM. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenterie ar- tery. BJU Int, 2010, 106: 199-205.
  • 7Srivastava P, Mandhani A, Kapoor R, et al. Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North In- dian cohort. Ann Surg Oncol, 2010, 17: 3068-3075.
  • 8Herrmann E, Ehze E, Bierer S, et al. VEGF-C, VEGF-D and Fh-4 in transitional bladder cancer: relationships to clinicopatho- logical parameters and long-term survival. Anticancer Res, 2007, 27: 3127-3133.
  • 9Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410: 50- 56.
  • 10Wiley HE, Gonzalez EB, Maki W, et al. Expression of CC ebe- mokine receptor-7 and regional lymph node metastasis of B16 mu- rine melanoma. J Natl Cancer Inst, 2001, 93 : 1638-1643.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部